Study Stopped
Several prototype improvements affecting comfort and function were identified during the initial fit and range of motion testing and were deemed important to address prior to proceeding with the at-home testing phase.
Improving Arm Function Using Wearable Exoskeletons
Improving Arm Function After Stroke Using Synergy-Based Assistance in Wearable Exoskeletons
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this clinical trial is to compare arm and hand function with and without assistance from a wearable exoskeleton in individuals with neurological injury from a single stroke. The main questions it aims to answer are:
- Can a portable (i.e., body-mounted) shoulder exoskeleton increase the reachable workspace of an individual after stroke?
- Can shoulder assistance from a body-mounted exoskeleton improve hand function after stroke?
- Does shoulder assistance from a body-mounted exoskeleton lead to changes in functional use of the impaired limb at home? Participants will perform tasks with and without assistance from a portable exoskeleton, including:
- maximal area sweeps in each of three directional planes (sagittal, frontal, transverse).
- simultaneous wrist and finger extension while attempting to pick up objects of varying size from the Action Research Arm Test (ARAT), Wolf Motor Function Test (WMFT), and Box and Blocks (BBT) test kits.
- standardized clinical assessments in a laboratory setting that have been shown to correlate with functional performance of activities of daily living including WMFT, ARAT, and BBT.
- a Motor Activity Log (MAL) based on activity performed in the past week as a baseline, before wearing the exoskeleton at home for a period of 1-2 hours per day for at least 5 days.
- a System Usability Scale and a second MAL corresponding with the activities performed while wearing the exoskeleton during the at-home phase. Researchers will compare functional ability measures with and without wearing the portable shoulder exoskeleton to see if the assistance improves functional performance in the arm and/or hand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 19, 2023
CompletedStudy Start
First participant enrolled
June 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
May 4, 2026
April 1, 2026
2.9 years
June 15, 2023
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
BBT change in score
Percent change in Box and Blocks Test score WITH vs. WITHOUT the assistive exoskeleton. Blocks are moved from one bin over a barrier to another bin in 1 minute. The number of blocks successfully transferred over the barrier is the score. BBT Minimum scale value = 0 (worst performance). BBT improvement = ( (score with exo) - (score without exo) ) / (score without exo) \* 100
Scores with and without exoskeleton assistance are measured during a single session not more than 30 minutes apart.
ARAT change in score
Percent change in Action Research Arm Test score WITH vs. WITHOUT the assistive exoskeleton. 19 tasks are scored on a scale from 0-3. ARAT Minimum scale value = 0 (worst performance). ARAT Maximum scale value = 57 (best performance). ARAT improvement = ( (score with exo) - (score without exo) ) / (score without exo) \* 100
Scores with and without exoskeleton assistance are measured during a single session not more than 30 minutes apart.
Secondary Outcomes (2)
Unassisted Arm Use at Home (without device)
up to 5 days
Unassisted Arm Use at Home (with device)
up to 5 days
Other Outcomes (2)
Motor Activity Log
up to 2 weeks
Range of motion change
up to 2 weeks
Study Arms (1)
Chronic Stroke
EXPERIMENTALIndividuals more than 6 months post-stroke in stable condition with long-term impairment affecting the arm and hand.
Interventions
The wearable shoulder exoskeleton prototype is under development at the University of Idaho to provide gravity support to the shoulder. Subjects will use the device at home for a period of 3-5 days for at least 2 hours per day.
The wearable hand exoskeleton prototype is under development at the University of Idaho to provide hand-opening support. Subjects will use the device at home for a period of 3-5 days for at least 2 hours per day.
Eligibility Criteria
You may qualify if:
- have arm and hand impairment resulting from a single stroke that occurred more than 6 months ago.
- have some volitional extension of the wrist and fingers to grasp small objects and the ability to elevate the shoulder at least 15 degrees.
You may not qualify if:
- currently pregnant
- under 18
- incarcerated
- severe pain with arm or hand movement
- inability to understand verbal or visual instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Idaholead
- University of California, Irvinecollaborator
Study Sites (1)
University of Idaho Integrated Research and Innovation Center
Moscow, Idaho, 83844, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joel C Perry, PhD
University of Idaho
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 15, 2023
First Posted
July 19, 2023
Study Start
June 18, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available at the conclusion of the study for at least 25 years.
- Access Criteria
- There will be no restrictions for access to deidentified data, both summarized and individual.
The results of the study will be presented at conferences, targeting the Annual Society of Neurorehabilitation and at the annual Mountain West Clinical \& Translational Research Infrastructure Network (MW CTR-IN) conference in Las Vegas, Nevada. We plan to disseminate the full results of the trial via appropriate peer-reviewed journals in a timely manner and make de-identified datasets available via the University of Idaho Library. The informed consent documents for the clinical trial will include a specific statement relating to posting of clinical trial information at ClinicalTrials.gov. All data from individual participants will be anonymized or provided in aggregate form prior to sharing.